1. Home
  2. NEUP vs RVYL Comparison

NEUP vs RVYL Comparison

Compare NEUP & RVYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUP
  • RVYL
  • Stock Information
  • Founded
  • NEUP 1996
  • RVYL 2007
  • Country
  • NEUP United States
  • RVYL United States
  • Employees
  • NEUP N/A
  • RVYL N/A
  • Industry
  • NEUP
  • RVYL Professional Services
  • Sector
  • NEUP
  • RVYL Consumer Discretionary
  • Exchange
  • NEUP Nasdaq
  • RVYL Nasdaq
  • Market Cap
  • NEUP 12.7M
  • RVYL 10.3M
  • IPO Year
  • NEUP N/A
  • RVYL N/A
  • Fundamental
  • Price
  • NEUP $7.20
  • RVYL $0.32
  • Analyst Decision
  • NEUP Strong Buy
  • RVYL Hold
  • Analyst Count
  • NEUP 1
  • RVYL 1
  • Target Price
  • NEUP $21.00
  • RVYL N/A
  • AVG Volume (30 Days)
  • NEUP 38.6K
  • RVYL 3.4M
  • Earning Date
  • NEUP 08-19-2025
  • RVYL 08-19-2025
  • Dividend Yield
  • NEUP N/A
  • RVYL N/A
  • EPS Growth
  • NEUP N/A
  • RVYL N/A
  • EPS
  • NEUP 0.00
  • RVYL N/A
  • Revenue
  • NEUP $15,662,715.00
  • RVYL $54,357,000.00
  • Revenue This Year
  • NEUP N/A
  • RVYL $27.50
  • Revenue Next Year
  • NEUP N/A
  • RVYL $35.71
  • P/E Ratio
  • NEUP $4,211.30
  • RVYL N/A
  • Revenue Growth
  • NEUP N/A
  • RVYL N/A
  • 52 Week Low
  • NEUP $2.90
  • RVYL $0.25
  • 52 Week High
  • NEUP $126.00
  • RVYL $2.35
  • Technical
  • Relative Strength Index (RSI)
  • NEUP N/A
  • RVYL 40.08
  • Support Level
  • NEUP N/A
  • RVYL $0.29
  • Resistance Level
  • NEUP N/A
  • RVYL $0.33
  • Average True Range (ATR)
  • NEUP 0.00
  • RVYL 0.02
  • MACD
  • NEUP 0.00
  • RVYL 0.02
  • Stochastic Oscillator
  • NEUP 0.00
  • RVYL 81.56

About NEUP Neuphoria Therapeutics Inc. Common Stock

Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.

About RVYL Ryvyl Inc.

Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.

Share on Social Networks: